ArticleFrontiers in immunology2026
Integrated transcriptomic profiling of rectal and adipose HIV-1 reservoirs relative to matched PBMCs in ART-treated individuals.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: HIV-1 persistence in anatomical reservoirs remains the primary obstacle to a functional cure, even under suppressive antiretroviral therapy (ART). While gut-associated lymphoid tissue (GALT) is a well-recognized site of viral sequestration, the role of adipose tissue as an immunometabolic sanctuary, and its distinct host immune environment compared with peripheral blood remain under-characterized. Methods: In this study, we quantified the HIV-1 DNA reservoir using droplet digital PCR (ddPCR) in rectal tissues and subcutaneous adipose tissues (SAT), each paired with matched peripheral blood mononuclear cells (PBMCs) from ART-treated individuals. To characterize the host transcriptomic landscape associated with viral persistence, RNA-seq was performed across these compartments. An external healthy human tissue dataset (GSE120795) was integrated to perform background-identity filtering. Key differentially expressed signatures and enriched pathways were further validated using RT-qPCR and Western blot. Results: The ddPCR analysis confirmed significantly higher viral DNA loads in both rectal and adipose tissues relative to matched PBMCs, identifying them as major anatomical reservoirs. Transcriptomic profiling after background filtering revealed divergent host responses: rectal reservoirs were primarily characterized by extracellular matrix (ECM) reorganization and epithelial barrier dysfunction, whereas SAT exhibited prominent dysregulation in cell cycle progression and immunometabolic signaling. Notably, cross-tissue enrichment analysis identified the PI3K-Akt signaling pathway as a common transcriptomeic feature across these anatomical sites. Validation experiments confirmed that fibrosis-associated hub gene Conclusion: Our study provides a comprehensive landscape of tissue-specific transcriptomic remodeling in rectal and adipose HIV-1 reservoirs. These findings suggest that persistent viral sequestration is associated with distinct microenvironmental alterations, ranging from fibrotic shifts to metabolic dysregulation, which share common molecular features such as potentially linked to the PI3K-Akt axis. This work underscores the importance of targeting anatomical sanctuaries beyond the peripheral blood in future HIV-1 cure strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.